Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Mouse embryonic stem cells (ESCs) are isolated from the inner cell mass of blastocysts, and they exist in different states of pluripotency-naïve and primed states. Pten is a well-known tumor suppressor. Here, we generated Pten-/- mouse ESCs with the CRISPR-Cas9 system and verified that Pten-/- ESCs maintained naïve pluripotency by blocking Gsk3β activity. Serum/LIF and 2i (MAPK and GSK3 inhibitors) conditions are commonly used for ESC maintenance. We show that the Pten-inhibitor SF1670 contributed to sustaining mouse ESCs and that Pten activation by the S380A, T382A, and T383A mutations (Pten-A3) suppressed the pluripotency of ESCs. The in vivo teratoma formation ability of SF1670-treated ESCs increased, while the Pten-A3 mutations suppressed teratoma formation. Furthermore, the embryoid bodies derived from Pten-deficient ESCs or SF1670-treated wild-type ESCs showed greater expression of ectoderm and pluripotency markers. These results suggest that Pten-mediated Gsk3β modulates the naïve pluripotency of ESCs and that Pten ablation regulates the lineage-specific differentiation.

Citation

Wuming Wang, Gang Lu, Xianwei Su, Chengcheng Tang, Hongjian Li, Zhiqiang Xiong, Chi-Kwan Leung, Man-Sze Wong, Hongbin Liu, Jin-Long Ma, Hoi-Hung Cheung, Hsiang-Fu Kung, Zi-Jiang Chen, Wai-Yee Chan. Pten-mediated Gsk3β modulates the naïve pluripotency maintenance in embryonic stem cells. Cell death & disease. 2020 Feb 07;11(2):107

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 32034125

View Full Text